Panavir rectal 0.2mg 5 pcs

Description

Composition
Active substance:
1 suppository contains: panavir® (polysaccharides shoots Solanum tuberosum) – 200 micrograms.
Excipients:
Confectionery fat or fat solid – 1.0198 g paraffin – 0.0900 g, emulsifier T-2 – 0.0900 g Weight of suppository – 1.2 g
Description:
Suppositories from white to white color with a yellowish shade, conical or cylindrical shape tolerance of yellowish gray specks, odorless.
Product form:
200 g rectal suppositories.
5 suppositories in blisters, 1 contour cellular packaging together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity.
Pregnancy.
Lactation.
Childhood.
Dosage
0.2 mg
Indications
Herpesvirus infections of different localization (including recurrent genital herpes, herpes zoster and ophthalmoherpes).
Secondary immunodeficiency state against infectious diseases.
Cytomegalovirus infection, including patients with recurrent miscarriage. It is used in women with chronic viral infection and interferonodefitsitnym state in preparation for pregnancy.
Human papillomavirus infection (anogenital warts) in the complex therapy.
Tick-borne encephalitis in order to reduce viral load and removal of neurological symptoms (anizorefleksii, reduce reflections, pain exit points of cranial nerves, nystagmus) in a complex therapy.
SARS and influenza in the complex therapy.
Interaction with other drugs
Not registered.
Overdose
Cases of overdose are not logged in. Preclinical studies indicate low toxicity.
pharmachologic effect
Pharmacological group:
Antiviral and immunomodulatory agent.
Pharmacodynamics:
Panavir® – a purified extract of the plant shoots Solanum tuberosum; the main active substance – hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir® drug is an antiviral and immunomodulatory agent. Increases nonspecific resistance to infections and promotes the induction of interferons alpha and gamma blood leukocytes.
formulation was well tolerated in therapeutic doses.
Tests showed no mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic action. In preclinical studies in laboratory animals, adverse effects on reproduction and fetal development has not been established.
It has anti-inflammatory properties in experimental models of edema, exudative.
Pharmacokinetics:
The pharmacokinetics of the drug has not been studied due to its chemical nature and small doses applicable.
Pregnancy and breast-feeding
If necessary, use during lactation breastfeeding at the time of taking the medication should be discontinued.
Conditions of supply of pharmacies
Prescription.
side effects
The drug was well tolerated, complications may be associated with individual intolerance and enhanced sensitivity to the constituents of the preparation.
However, the appearance of any adverse side effects need to stop administering the drug and to consult with a physician.
If you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Effects on ability to drive a vehicle, the mechanism
Data on the possible negative impact of the drug on the ability to drive vehicles and the implementation of potentially hazardous activities that require attention and psychomotor speed reactions, no.
Storage conditions
In a dry, dark place at a temperature of 2 to 8 ° C.
Keep out of the reach of children.
Dosing and Administration
Rectally.
For treatment of herpesvirus infections and tick-borne encephalitis 1 suppository used twice with an interval of 48 or 24 hours. If necessary, treatment can be repeated after one month.
For the treatment of cytomegalovirus infection and papillomavirus apply 1 suppository trisubstituted in the first week at intervals of 48 hours, and twice during the second week at intervals of 72 hours.
For the treatment of influenza and SARS 1 suppository used at 24 h intervals for 5 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist